G. Dauneanglard et al., SOME BIOCHEMICAL AND PATHOPHYSIOLOGICAL ASPECTS OF LONG-TERM ELEVATION OF BRAIN ORNITHINE CONCENTRATIONS, Pharmacology & toxicology, 73(1), 1993, pp. 29-34
Mice and chicken were given 5-fluoromethylornithine (5FMOrn), a select
ive inactivator of ornithine aminotransferase (OAT) over extended peri
ods of time. This treatment allowed us to maintain elevated concentrat
ions of ornithine in all tissues. Since gyrate atrophy, an autosomal r
ecessive human disease, is characterized by the absence of OAT, specia
l emphasis was put on the study of the visual system. Ophthalmoscopic
and histologic examinations of the eye as well as electroretinograms a
nd locomotor behaviour demonstrated an unimpaired visual system and br
ain. No toxic effects were observable in the treated mice. Likewise, c
hick embryo development was normal in spite of highly elevated brain a
nd tissue ornithine concentrations. A likely explanation for the absen
ce of toxic effects of 5FMOrn treatment, disregarding the non-toxicity
of ornithine, is the fact that 10-20% of tissue OAT is refractory to
inactivation by 5FMOrn. This residual activity may be sufficient to ma
intain vital functions.